Rendering of the planned building at 400 Summer St. (WS Development)
September 23, 2021 10:32 AM EDTUpdated 10:51 AM
Pharma

Roche's Foun­da­tion Med­i­cine is get­ting a new 16-sto­ry home in Boston's Sea­port Dis­trict

Paul Schloesser

Associate Editor

A de­vel­op­er and an in­vest­ment firm have joined to­geth­er to add yet an­oth­er biotech build­ing to Boston’s sky­line. And to­day, a pri­vate eq­ui­ty firm has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times